- $3.88bn
- $8.53bn
- $1.13bn
- 54
- 62
- 66
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 837 | 898 | 955 | 1,097 | 1,130 |
Cost of Revenue | |||||
Gross Profit | 591 | 642 | 689 | 781 | 785 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 615 | 659 | 685 | 772 | 800 |
Operating Profit | 222 | 239 | 270 | 325 | 330 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 215 | 207 | 659 | 259 | 238 |
Net Income After Taxes | 215 | 207 | 659 | 259 | 238 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 195 | 187 | 628 | 233 | 212 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 193 | 185 | 627 | 231 | 211 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.51 | 1.44 | 1.5 | 1.83 | 1.8 |
Dividends per Share |